| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | OSI-930 | CTRPv2 | pan-cancer | AAC | 0.0028 | 0.9 |
| mRNA | BRD-K70511574 | CTRPv2 | pan-cancer | AAC | 0.0025 | 0.9 |
| mRNA | necrostatin-1 | CTRPv2 | pan-cancer | AAC | 0.0028 | 0.9 |
| mRNA | GSK1059615 | CTRPv2 | pan-cancer | AAC | 0.0034 | 0.9 |
| mRNA | neratinib | CTRPv2 | pan-cancer | AAC | 0.0025 | 0.9 |
| mRNA | temsirolimus | CTRPv2 | pan-cancer | AAC | 0.0034 | 0.9 |
| mRNA | BRD-K16130065 | CTRPv2 | pan-cancer | AAC | -0.0045 | 1 |
| mRNA | RAF265 | CTRPv2 | pan-cancer | AAC | -0.0025 | 1 |
| mRNA | AZ-3146 | CTRPv2 | pan-cancer | AAC | -0.0021 | 1 |
| mRNA | BRD6340 | CTRPv2 | pan-cancer | AAC | 0.0016 | 1 |